Noble Financial Starts Evoke Pharma (EVOK) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Brean Capital Reiterates Buy After Evoke Pharma (EVOK) Extends Interest-Payment-Only Period
October 7, 2015 11:52 AM EDTBrean Capital reiterated a Buy rating and $13.00 price target on Evoke Pharma (NASDAQ: EVOK) after negotiating for its interest-payment-only period to be extended for another year. The deal reduces Evokes debt payments by $2.2 million in the next year by eliminating principal payments and... More
